Pagari Life Science Corp.

BETHALTA, IL · Founded 2022 · CIK 0001993125 · Biotech · Private

Advanced anti-herpetic and wound-healing pharmaceutical drugs

pagarilifescience.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$678K
4 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
6
1 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$250,000
Private capital raisedForm D · SEC$275,000
Private capital raisedForm D · SEC$55,500
Private capital raisedForm D · SEC$97,494
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1176Cessation Therapeutics, Inc.—$6.8M
1177Dnalite Therapeutics, Inc.—$5.6M
1178Xenon Pharmaceuticals——
1179Pagari Life Science Corp.—$678K
1180PRIMAL THERAPIES, INC.—$677K
1181Grace Bio-Labs, Inc.——
1182NEUREXIS THERAPEUTICS, INC.—$605K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • David FeldkerDirector · Executive Officer
  • Stephen PeipertDirector · Executive Officer
  • Stephen PiepertDirector
  • Alan WickenhauserDirector
  • James WickenhauserExecutive Officer
  • Marni ZenkewiczExecutive Officer

Patents

USPTO · 1 granted of 6
  • Compositions For Treating Genital Herpes And Methods Of Their Useapplication
  • Treatment Of Herpes Zoster With Topical Tetracainegranted
  • Treatment Of Herpes Zoster With Topical Tetracaineapplication
  • Compositions For Treating Genital Herpes And Methods Of Their Useapplication
  • Compositions For Treating Genital Herpes And Methods Of Their Useapplication
  • Treatment Of Herpes Zoster With Topical Tetracaineapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.